Synergistic inhibition of hepatitis C virus infection by a novel microtubule inhibitor in combination with daclatasvir

Even though substantial progress has been made in the treatment of hepatitis C virus (HCV) infection, viral resistance and relapse still occur in some patients and additional therapeutic approaches may ultimately be needed should viral resistance become more prevalent. Microtubules play important ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huijun, Zhang, Xing-Quan, Huang, Lina S., Fang, Xiong, Khan, Mohsin, Xu, Yan, An, Jing, Schooley, Robert T., Huang, Ziwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136107/
https://www.ncbi.nlm.nih.gov/pubmed/35647321
http://dx.doi.org/10.1016/j.bbrep.2022.101283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136107/
https://www.ncbi.nlm.nih.gov/pubmed/35647321
http://dx.doi.org/10.1016/j.bbrep.2022.101283

Ejemplares similares